Adverse drug reactions: Treatment burdens and nurse-led medication monitoring

Journal of Nursing Management

Volumn 19, Issue 3, 2011, Pages 377-392

  Gabe, Marie E ^a   Davies, Gwyneth A ^a,b   Murphy, Fiona ^a   Davies, Michelle ^c   Johnstone, Linzi ^c   Jordan, Sue ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b ABERTAWE BRO MORGANNWG UNIVERSITY HEALTH BOARD   (United Kingdom)

^c SINGLETON HOSPITAL   (United Kingdom)

Author keywords

Adverse drug reactions; Adverse events; Nurse led medication monitoring; Patient safety; Pharmacovigilance

Indexed keywords

ARTICLE; CLINICAL COMPETENCE; DRUG MONITORING; DRUG TOXICITY; EDUCATIONAL STATUS; HUMAN; INTERPERSONAL COMMUNICATION; METHODOLOGY; NURSE ATTITUDE; NURSING; PATIENT CARE; SAFETY;

CLINICAL COMPETENCE; COMMUNICATION; DRUG MONITORING; DRUG TOXICITY; EDUCATIONAL STATUS; HUMANS; NURSE'S ROLE; PATIENT CARE; SAFETY;

EID: 79954992694     PISSN: 09660429     EISSN: 1365263X     Source Type: Journal    
DOI: 10.1111/j.1365-2834.2011.01204.x     Document Type: Article

References (151)

1. Allen D. & Hughes D. (2002) Expanded nursing roles: different occupational perspectives. In Nursing and the Division of Labour in Healthcare (D. Allen, D. Hughes, S. Jordan, M. Prowse & S. Snelgrove eds), pp. 99-128, Palgrave MacMillan, Basingstoke.
2. Al-Shaqha W.M.S. & Zairi M. (2001) Pharmaceutical care management: a modern approach to providing seamless and integrated health care. International Journal of Health Care Quality Assurance 14 (7), 282-301.
3. Aranaz-Andrés J.M., Aibar-Remón C., Vitaller-Murillo J., Ruiz-López P., Limón-Ramírez R. & Terol-García E. (2008) Incidence of adverse events related to health care in Spain: results of the Spanish National Study of Adverse Events. Journal of Epidemiology of Community Health 62 (12), 1022-1029.
4. Aronson J.K. (2004) In defence of polypharmacy. British Journal of Clinical Pharmacology 57 (2), 119-120.
5. Aronson J.K.(ed.) (2006) Meyle's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 15th edn. Elsevier, London.
6. Audit Commission (2001) A Spoonful of Sugar. Medicines Management in the NHS Hospitals. Audit Commission, London.
7. Avorn J. & Shrank W.H. (2008) Adverse drug reactions in elderly people. British Medical Journal 336, 956-957.
8. Baker G.R., Norton P.G., Flintoft V. et al. (2004) The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. Canadian Medical Association Journal 170 (11), 1678-1686.
9. Bartlett G., Blais R., Tamblyn R., Clermont R.J. & MacGibbon B. (2008) Impact of patient communication problems on the risk of preventable adverse events in acute care settings. Canadian Medical Association Journal 178 (12), 1555-1562.
10. Bates D.W. & Gawande A.A. (2003) Improving Safety with Information Technology. New England Journal of Medicine 348 (25), 2526-2534.
11. Beattie A. (1994) Healthy Alliance or dangerous liaisons? The challenge of working together in health promotion. In Going-Inter-Professional. Working Together for Health and Welfare (A. Leathard ed), pp. 109-122, Routledge, London.
12. Beijer H.J.M. & de Blaey C.J. (2002) Hospitalisation caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharmacy World and Science 24 (2), 46-54.
13. Belton K.J., Lewis S.C., Payne S. & Rawlins M.D. (1995) Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. British Journal of Clinical Pharmacology 39 (3), 223-226.
14. Berwick D.M., Enthoven A. & Bunker J.P. (1992) Quality management in the NHS: the doctor's role-1. British Medical Journal 304, 235-239.
15. Blenkinsopp A., Wilkie P., Wang M. & Routledge P.A. (2007) Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. British Journal of Clinical Pharmacology 63 (2), 148-156.
16. Brennan T.A., Leape L.L., Laird N.M. et al. (1991) Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study 1. New England Journal of Medicine 324, 370-376.
17. British National Formulary (2010) British National Formulary 59. British Medical Association and the Royal Pharmaceutical Society of Great Britain, London.
18. Brvar M., Fokter N., Bunc M. & Mozina M. (2009) The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department speciality. BMC Clinical Pharmacology 9, 8.
19. Budnitz D., Pollock D., Weidenbach K., Mendelsohn A., Schroeder T. & Annest J. (2006) National surveillance of emergency department visits for outpatient adverse drug events. Journal of the American Medical Association 296, 1858-1866.
20. Budnitz D.S., Shehab N., Kegler S.R. & Richards C.L. (2007) Medication use leading to emergency department visits for adverse drug events in older adults. Annals of Internal Medicine 147 (11), 755-765.
21. Chan M., Nicklason F. & Vial J.H. (2001) Adverse drug events as a cause of hospital admission in the elderly. Internal Medicine Journal 31 (4), 199-205.
22. Classen D.C., Pestotnik S.L., Evans R.S. & Burke J.P. (1991) Computerized surveillance of adverse drug events in hospital patients. Journal of the American Medical Association 266 (20), 2847-2851.
23. Committee of Public Accounts (2006) A Safer Place for Patient: Learning to improve patient safety. The Stationary Office Limited, London. Available at:, accessed 16 July 2010.
24. Cooper M.A., Lindsay G.M., Kinn S. & Swann I.J. (2002) Evaluating emergency nurse practitioner services: a randomised controlled trial. Journal of Advanced Nursing 40 (6), 721-730.
25. Cumming R.G., Mitchell P. & Leeder S.R. (1997) Use of inhaled corticosteroids and the risk of cataracts. New England Journal of Medicine 337, 8-14.
26. Davies E.C., Green C.F., Taylor S., Williams P.R., Mottran D.R. & Pirmohamed M. (2009) Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS ONE 4 (2), e4439.
27. Davies M.A., Conley Y. & Puskar K. (2010) Incorporating evidence from pharmacological and pharmacogenetic studies of atypical antipsychotic drugs into advanced psychiatric nursing practice. Perspectives in Psychiatric Care 46 (2), 98-107.
28. De Vries E.N., Ramrattan M.A., Gouma D.J. & Boermeester M.A. (2008) The incidence and nature of in-hospital adverse events: a systematic review. Quality and Safety in Health Care 17, 216-223.
29. Department of Health (2000a) An Organisation with a Memory: Report of an Expert Group on Learning from Adverse Events in the NHS. The Stationery Office, London.
30. Department of Health(2000b) A Health Service of all the Talents: Developing the NHS Workforce. The Stationery Office, London.
31. Department of Health (2001) Medicines for Older People: Implementing Medicines-related Aspects of the NSF for Older People. The Stationery Office, London.
32. Department of Health (2004) Agenda for Change. Final Agreement. Department of Health, London.
33. Department of Health (2008) Medicines Management: Everybody's Business. Department of Health, London.
34. Dilles T., Stichele R.V., Rompaey B.V., Bortel L.V. & Elseviers M. (2010) Nurses' practices in pharmacotherapy and their association with educational level. Journal of Advanced Nursing 66 (5), 1072-1079.
35. Donnan P.T., Libby G., Boyter A.C. & Thompson P. (2005) The population risk of fractures attributable to oral corticosteroids. Pharmacoepidemiology and Drug Safety 14 (3), 177-186.
36. Dormann A., Neubert M., Criegee-Rieck M. et al. (2004) Readmissions and adverse drug reactions in internal medicine: the economic impact. Journal of Internal Medicine 255, 653-663.
37. Douglas J. (2009) Chapter 1: The rise of modern multidisciplinary public health. In A Reader in Promoting Public Health. Challenge and Controversy, 2nd edn (J. Douglas, S. Earler, S. Handsley, L. Jones, C.E. Lloyd & S. Spurr eds), pp. 9-14, The Open University, SAGE Publications, Milton Keynes.
38. Dowling S., Martion R., Skidmore P., Doyal L., Cameron A. & Lloyd S. (1996) Nurses taking on junior doctors' work: a confusion of accountability. British Medical Journal 312 (7040), 1211-1214.
39. Dunson T.R. & Morfin E. (2010) Chapter 9: managing drug safety risk. In Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries (P. Harpum ed), pp. 155-174, Wiley, Hoboken, NJ.
40. Edwards I.R. & Aronson J.K. (2000) Adverse drug reactions: definitions, diagnosis and management. The Lancet 356 (9237), 1255-1259.
41. Ekman E. & Bäckström M (2009) Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden. European Journal of Clinical Pharmacology 65 (1), 43-46.
42. Fitzmaurice D.A., Hobbs R., Murray E.T., Holder R.L., Allan T.F. & Rose P.E. (2000) Oral anticoagulation management in primary care with the use of computerized decision support and near-patient testing. Archives of Internal Medicine 160, 2343-2348.
43. Flin R. & Yule S. (2004) Leadership for safety: industrial experience. Quality and Safety in Health Care 13 (s2), 45-51.
44. Forster A.J., Murff H.J., Peterson J.F., Gandhi T.K. & Bates D.W. (2003) The incidence and severity of adverse events affecting patients following discharge from the hospital. Annals of Internal Medicine 138 (3), 161-167.
45. Forster A.J., Murff H.J., Peterson J.F., Gandhi T.K. & Bates D. (2005) Adverse drug events occurring following hospital discharge. Journal of General Internal Medicine 20 (4), 317-323.
46. Foster J.M., Aucott L., Van Der Werf R.H.W. et al. (2006a) Higher patient perceived side effects to higher daily disease of inhaled corticosteroids in the community: a cross-sectional analysis. Respiratory Medicine 100 (8), 1318-1336.
47. Foster J.M., Sonderen E.V., Lee A.J. et al. (2006b) A self rating scale for patient-perceived side effects of inhaled corticosteroids. Respiratory Research 7, 131.
48. Freidson E. (1988) The Profession of Medicine. The Study of the Sociology of the Applied Knowledge, reprinted edn. University of Chicago Press, Chicago, IL.
49. Gandhi T.K., Burstin H.R., Cook E.F. et al. (2000) Drug complications in outpatients. Journal of General Internal Medicine 15 (3), 149-154.
50. Gandhi T.K., Weingart S.N., Borus J. et al. (2003) Adverse drug events in ambulatory care. New England Journal of Medicine 348 (16), 1556-1564.
51. Gillespie U., Alassaad A., Henrohn D. et al. (2009) A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older. Archives of Internal Medicine 169 (9), 894-900.
52. Ginsburg L.R., Chuang Y., Berta W.B. et al. (2010) Organizations, Market and Performance. Health Service Research 45 (3), 607-632.
53. Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2008) Global Strategy for the Diagnosis, Management and Prevention of COPD. Medical Communications Resources, Inc., GIG Harbor, Washington. Available at: (accessed 09 February 2011).
54. Green C.F., Mottran D.R., Rowe P.H. & Pirmohamed M. (2000) Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study. Journal of Clinical Pharmacy and Therapeutics 25 (5), 355-361.
55. Griffiths T.H. & Jordan S. (2002) Corticosteroids: implications for nursing practice. Nursing Standard 17 (12), 43-53.
56. Gupta P. & O'Mahony M.S. (2008) Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people. Drugs and Aging 25 (5), 415-443.
57. Gurwitz J.H., Field T.S., Avorn J. et al. (2000) Incidence and preventability of adverse drug events in nursing homes. American Journal of Medicine 109, 87-94.
58. Gurwitz J.H., Field T.S., Harrold L.R. et al. (2003) Incidence and preventability of adverse drug events among older persons in the ambulatory setting. Journal of the American Medical Association 289 (9), 1107-1116.
59. Gurwitz J.H., Field T.S., Judge J. et al. (2005) The incidence of adverse drug events in two large academic long-term care facilities. American Journal of Medicine 118 (3), 251-258.
60. Halbert R.J., Natoli J.L., Gano A., Badamgarav E., Buist A.S. & Mannino D.M. (2006) Global burden of COPD: systematic review and meta-analysis. European Respiratory Journal 28 (3), 523-532.
61. Holroyd C., Cooper C. & Dennison E. (2008) Epidemiology of osteoporosis. Clinical Endocrinology and Metabolism 22 (5), 671-685.
62. Hopf Y., Watson M. & Williams D. (2008) Adverse-drug-reaction related to admissions to a hospital in Scotland. Pharmacy and World Science 30, 854-862.
63. Howard R.L. & Avery A.J. (2009) Chapter 11. Medicines management. In Health Care Errors and Patient Safety (B. Hurwitz & A. Sheikh eds), pp. 150-165, Wiley-Blackwell, Oxford.
64. Howard R.L., Avery A.J., Howard P.D. & Partridge M. (2003) Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Quality and Safety in Health Care 12 (4), 280-285.
65. Howard R., Avery A., Slavenburg S. et al. (2007) Which drugs cause preventable admissions to hospital? A systematic review. British Journal of Clinical Pharmacology 63 (2), 136-147.
66. Howard R., Avery A. & Bissell P. (2008) Causes of preventable drug-related hospital admissions: a qualitative study. Quality Safety in Health Care 17, 109-116.
67. Hsaio G., Chen I., Yu S., Wei L., Fang Y. & Tang F. (2010) Nurses' knowledge of high-alert medications: instrument development and validation. Journal of Advanced Nursing 66 (1), 177-190.
68. Hughes D. (2002) Nursing and the division of labour: sociological perspectives. In Nursing and the Division of Labour in Healthcare (D. Allen, D. Hughes, S. Jordan, M. Prowse & S. Snelgrove eds), pp. 1-22, Palgrave MacMillan, Basingstoke.
69. Hunt J.M. & Gjoka G. (2003) Nurse reporting of adverse events caused by medicines. Nursing Times 99 (49), 24-25.
70. International Conference of Harmonization (ICH)(1996) ICH Harmonised Tripartite Guideline for Good Clinical Practice. Institute of Clinical Research, Marlow. Available at:, accessed 16 July 2010.
71. Jennings N., Lee G., Chao K. & Keating S. (2009) A survey of patient satisfaction in a metropolitan Emergency Department: comparing nurse practitioners and emergency physicians. International Journal of Nursing Practice 15 (3), 213-218.
72. Jha A.K., Prasopa-Plaizier N., Larizgoitia I. & Bates D.W. (2010) Patient safety research: an overview of the global evidence. Quality and Safety in Health Care 19 (1), 42-47.
73. Jordan S. (2002) Managing adverse drug reactions: an orphan task. Developing nurse-administered evaluation checklists. Journal of Advanced Nursing 38 (5), 437-448.
74. Jordan S. (2007) Adverse drug reactions: reducing the burden of treatment. Nursing Standard 21 (34), 35-41.
75. Jordan S. (2008) The Prescription Drug Guide for Nurses. Open University Press/McGraw-Hill, Maidenhead.
76. Jordan S. & Griffiths T.H. (2004) Prescription drugs: uses and effects. Corticosteroids. Nursing Standard 18 (27), S1-S2.
77. Jordan S. & Hughes D. (1996) Bioscience knowledge and the health care professions. Social Science in Health 2 (2), 80-92.
78. Jordan S., Jones R. & Sargeant M. (2009) Adverse drug reactions: managing the risk. Journal of Nursing Management 17 (2), 175-184.
79. Jordan S., Tunnicliffe C. & Sykes A. (2002) Minimising side effects: the clinical impact of nurse-administered 'side effect' checklists. Journal of Advanced Nursing 37 (2), 155-165.
80. Jordan S., Knight J. & Pointon D. (2004) Monitoring adverse drug reactions: scales, profiles and checklists. International Nursing Review 51, 208-221.
81. Kanjanarat P., Winterstein A.G., Johns T.E., Hatton R.C., Gonzalez-Roothi R. & Segal R. (2003) Nature of preventable adverse drug events in hospitals: a literature review. American Journal of Health-System Pharmacy 60 (17), 1750-1759.
82. King R.L. (2004) Nurses' perception of their pharmacology educational needs. Journal of Advanced Nursing 45 (4), 392-400.
83. Kinirons M.T. & O'Mahony M.S. (2004) Drug metabolism and ageing. British Journal of Clinical Pharmacology 57 (5), 540-544.
84. Kohn L., Corrigan J.M. & Donaldson M.S. & Institute of Medicine. (1999) To Err is Human. Building a Safer Health System. National Academy Press, Washington, DC.
85. Kvasz M., Allen I.E., Gordon M.J., Estok R., Olkin I. & Ross S.D. (2000) Adverse drug reactions in hospitalised patients: a critique of a meta-analysis. Medscape General Medicine 2 (2), E3.
86. Kyriacos U., Jordan S. & Van Den Heever J. (2005) The biological sciences in nursing: a developing country perspective. Journal of Advanced Nursing 52 (1), 91-103.
87. Lagnaoui R., Moore N., Fach J., Longy-Boursier M. & Bégaud B. (2000) Adverse drug reactions in a department of systemic disease-orientated internal medicine: prevalence. Incidence, direct costs and avoidability. European Journal of Clinical Pharmacology 56 (2), 181-186.
88. Latter S., Maben J., Myall M., Young A. & Baileff A. (2007) Evaluating prescribing competencies and standards in nurse independent prescribers' prescribing consultations. Journal of Research in Nursing 12 (1), 7-26.
89. Laurant M., Reeves D., Hermens R., Braspenning J., Grol R. & Sibbald B. (2004) Substitution of doctors by nurses in primary care. Cochrane Database of Systematic Reviews 4, CD001271.
90. Lazarou J., Pomeranz B.H. & Corey P.N. (1998) Incidence of adverse drug reactions in hospitalised patients: a meta-analysis of prospective studies. Journal of the American Medical Association 279, 1200-1205.
91. Leape L., Berwick D., Clancy C. et al. (2009) Transforming healthcare: a safety imperative. Quality and Safety in Health Care 18, 424-428.
92. Leendertse A.J., Egberts A.C.G., Stoker L.J., van den Bemt P.M.L.A. & for the HARM Study Group. (2008) Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Archives of Internal Medicine 168 (17), 1890-1896.
93. Light D.W. (2001) Managed competition, governmentality and institutional response in the United Kingdom. Social Science and Medicine 52, 1167-1181.
94. Mador M.J. & Bozkanat E. (2001) Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Respiratory Research 2, 216-224.
95. Mintzer J. & Burns A. (2000) Anticholinergic side-effects of drugs in elderly people. Journal of the Royal Society of Medicine 93, 457-462.
96. Mjörndal T., Boman M.D., Hägg S. et al. (2002) Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiology and Drug Safety 11 (1), 65-72.
97. Moore N. & Bégaud B. (2010) Improving pharmacovigilance in Europe. British Medical Journal 340, 1694.
98. Morrison-Griffiths S., Walley T., Park B., Breckenridge A. & Pirmohamed M. (2003) Reporting of adverse drug reactions by nurses. Lancet 361 (9366), 1347-1348.
99. Nakanishi M., Koyama A., Ito H., Kurita H. & Higuchi T. (2006) Nurses' collaboration with physicians in managing medication improves patient outcomes in acute psychiatric care. Psychiatry and Clinical Neurosciences 60 (2), 196-203.
100. National Co-ordinating Council for Medication Error Reporting and Prevention (2005) NCC MERP: The First Ten Years "Defining the Problem and Developing Solutions". United States Pharmacopia, Rockville, MD. Available at:, accessed 16 July 2010.
101. National Patient Safety Agency (2007) Safety in Doses: Medication Safety Incidents in the NHS. National Patient Safety Agency (NPSA), London.
102. Nguyen T.V., Hillman K.M. & Buist M.D. (2001) Adverse events in British hospitals. Prevention strategies, not epidemiological studies, are needed. British Medical Journal 322, 1425.
103. Norris T. & Melby V. (2006) The Acute Care Nurse Practitioner: challenging existing boundaries of emergency nurses in the United Kingdom. Journal of Clinical Nursing 15 (3), 253-263.
104. Nursing and Midwifery Council (2006) Standards of Proficiency for Nurse and Midwife Prescribers. Available at:, accessed 09 February 2011.
105. Nursing and Midwifery Council (2008) The Code: Standards of Conduct, Performance and Ethics for Nurses and Midwives. Available at:, accessed 09 February 2011.
106. Onder G., Pedone C., Landi F. et al. (2008) Adverse drug reactions as causes of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). Journal of the American Geriatrics Society 50 (12), 1962-1968.
107. O'Neil A.C., Petersen L.A., Cook E.F., Bates D.W., Lee T.H. & Brennan T.A. (1993) Physician reporting compared with medical-record review to identify adverse medical events. Annals of Internal Medicine 119 (5), 370-376.
108. Oshikoya K.A. & Awobusuyi J.O. (2009) Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clinical Pharmacology 9, 14.
109. Patel K.J., Kedia M.S., Bajpai D., Mehta S.S., Kshirsagar N.A. & Gogtay N.J. (2007a) Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clinical Pharmacology 7 (8), doi.
110. Patel H., Bell D., Molokhia M. et al. (2007b) Trends in hospital admissions for adverse drug reactions in England: analysis of national episode statistics 1998-2005. BMC Clinical Pharmacology 7, 9, doi.
111. Pattanaik S., Dhamija P., Malhotra S., Sharma N. & Pandhi P. (2009) Evaluation of cost of treatment of drug-related events in a tertiary care public sector hospital in Northern India: a prospective study. British Journal of Clinical Pharmacology 67 (3), 363-369.
112. Phansalkar S., Hoffman J.M., Nebeker J. & Hurdle J.F. (2007) Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review. American Journal of Health-System Pharmacy 64 (8), 842-849.
113. Phillips K.A., Veenstra D.L., Oren E., Lee J.K. & Sadee W. (2001) Potential role of pharmacogenomics in reducing adverse drug reactions. Journal of the American Medical Association 286 (18), 2270-2279.
114. Pirmohamed M., James S., Meakin S. et al. (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. British Medical Journal 329 (7456), 15-19.
115. Pourseyed S., Fattahi F., Pourpak Z. et al. (2009) Adverse drug reactions in patients in an Iranian department of internal medicine. Pharmacoepidemiology and Drug Safety 18 (2), 104-110.
116. Pouyanne P., Haramburu F., Imbs J.L. & Bégaud B. (2000) Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. British Medical Journal 320, 1036.
117. Ramesh M., Pandit J. & Parthasarathi G. (2003) Adverse drug reactions in a South Indian hospital - their severity and cost involved. Pharmacoepidemiol Drug Safety 12 (8), 687-692.
118. Rashid C. (2010) Benefits and limitations of nurses taking on aspects of the clinical role of doctors in primary care: integrative literature review. Journal of Advanced Nursing 66 (8), 1658-1670.
119. Review of Health and Social Care Burdens (2008) Lifting the Burdens Task Force. Local Government Association, London.
120. Rigolosi E.L.M. (2005) Management and Leadership in Nursing and Health Care: An Experiential Approach, 2nd edn. Springer Publishing Company, New York.
121. Rivkin A. (2007) Admissions to a medical intensive care unit related to adverse drug reactions. American Journal of Health-System Pharmacy 64 (17), 1840-1843.
122. Roig M., Eng J.J., Road J.D. & Reid W.D. (2009) Falls in patients with chronic obstructive pulmonary disease: a call for further research. Respiratory Medicine 103 (9), 1257-1269.
123. Routledge P.A., O'Mahony M.S. & Woodhouse K.W. (2004) Adverse drug reactions in elderly patients. British Journal of Clinical Pharmacology 57 (2), 121-126.
124. Royal College of General Practitioners (1985) What Sort of Doctor?: Assessing Quality of Care in General Practice. Report from General Practice No. 23. Royal College of General Practitioners, London.
125. Royal S., Smeaton L., Avery A.J., Hurwitz G. & Sheikh A. (2006) Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Quality in Safety Health Care 15, 23-31.
126. Ruiz B., García M., Aguirre U. & Aguirre C. (2008) Factors predicting hospital readmissions related to adverse drug reactions. European Journal of Clinical Pharmacology 64 (7), 715-722.
127. Sakr M., Angus J., Perrin J., Nixon C., Nicholl J. & Wardrope J. (1999) Care of minor injuries by emergency nurse practitioners or junior doctors: a randomised controlled trial. Lancet 354 (9187), 1321-1326.
128. Sale D. (2005) Understanding Clinical Governance and Quality Assurance: Making it Happen. Palgrave Macmillan, Basingstoke.
129. Sanders J.H. (2005) How much paperwork is too much? Family Practice Management 12 (1), 12.
130. Sari A.B.A., Cracknell A. & Sheldon T.A. (2008) Incidence, preventability and consequences of adverse events in older people: results of a retrospective case-note review. Age and Ageing 37, 265-269.
131. Shuto H., Imakyure O., Matsumoto J. et al. (2010) Medication use as a risk factor for inpatient falls in an acute care hospital: a case-crossover study. British Journal of Clinical Pharmacology 69 (5), 535-542.
132. Snelgrove S. & Hughes D. (2002) Perceptions of teamwork in acute medical wards. In Nursing and the Division of Labour in Healthcare (D. Allen, D. Hughes, S. Jordan, M. Prowse & S. Snelgrove eds), pp. 53-74, Palgrave MacMillan, Basingstoke.
133. Soop M., Frysmark U., Köster M. & Haglund B. (2009) The incidence of adverse events in Swedish hospitals: a retrospective medical records review study. International Journal for Quality in Health Care 21 (4), 285-291.
134. Sullivan E.J. & Decker P.J. (2005) Effective Leadership and Management in Nursing, 6th edn. Pearson Prentice Hall, Upper Saddle River, NJ.
135. Thomsen L.A., Winterstein A.G., Haugbølle L.S. & Melander A. (2007) Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Annals of Pharmacotherapy 41 (9), 1411-1426.
136. Thomson R. (2004) Adverse events reporting in English hospital statistics: data relevant to patient safety should not be presented alone and out of context. British Medical Journal 329, 857.
137. Thomson R., Lewalle P., Sherman H., Hibbert P., Runciman W. & Castro G. (2009) Towards an international classification for patient safety: a Delphi survey. International Journal for Quality in Health Care 21 (1), 9-17.
138. Thürmann P.A. (2001) Methods and systems to detect adverse drug reactions in hospitals. Drug Safety 24 (3), 961-968.
139. Turner-Warwick M. (2008) The patient-doctor partnership over 60years and the role of the royal medical colleges. Clinical Medicine 8 (6), 573-575.
140. Vincent C. (2006) Patient Safety. Churchill Livingstone, Edinburgh.
141. Vincent C., Neale G. & Woloshynowych M.M. (2001) Adverse events in British hospitals: preliminary retrospective review. British Medical Journal 332 (7285), 517-519.
142. Vincent C., Aylin P., Franklin B.D. et al. (2008) Is healthcare getting safer? British Medical Journal 337, a2426.
143. Wagner P.D. (2008) Possible mechanisms underlying the development of cachexia in COPD. European Respiratory Journal 31, 492-501.
144. Waller P.C. & Evans S.J.W. (2003) A model for the future conduct of pharmacovigilance. Pharmacoepidemiology and Drug Safety 12 (1), 17-29.
145. Walsh LJ., Wong C.A., Oborne J. et al. (2001) Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax 56 (4), 279-284.
146. Weingart S.N. & Page D. (2004) Implications for practice: challenges for healthcare leaders in fostering patient safety. Quality and Safety in Health Care 13 (Suppl II), ii52-ii56.
147. Welsh Assembly Government (2005) Designed for Life: Creating World Class Health and Social Care for Wales in the 21st Century. Welsh Assembly Government (WAG), Cardiff.
148. Winterstein A.G., Sauer B.C., Hepler C.D. & Poole C. (2002) Preventable drug-related hospital admissions. Annals of Pharmacotherapy 36, 1238-1248.
149. Woods D.M., Thomas E.J., Holl J.L., Weiss K.B. & Brennan T.A. (2007) Ambulatory care adverse events and preventable adverse events leading to a hospital admission. Quality and Safety in Health Care 16 (2), 127-131.
150. Wu T., Jen M., Bottle A. et al. (2010) Ten-year trends in hospital admissions for adverse drug reactions in England 1999-2009. Journal of the Royal Society of Medicine 103, 239-250.
151. Zhang M., Holman C.D.J., Price S.D., Sanfilippo F.M., Preen D.B. & Bulsata M.K. (2009) Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. British Medical Journal 338, a2752.